Stockreport

Ipsen And Sutro Partnering On ADCs Is A Deal Offering Opportunities For Investors [Seeking Alpha]

Sutro Biopharma, Inc.  (STRO) 
Last sutro biopharma, inc. earnings: 11/8 07:00 am Check Earnings Report
PDF The company generated $3.4bn in revenues in 2023, with a core consolidated net profit of $830m. Ipsen typically acquires relatively de-risked drug candidates in later [Read more]